EndaCof DH
Generic name: dihydrocodeine bitartrate, brompheniramine maleate and phenylephrine hydrochloride
Dosage form: liquid
Drug class:Upper respiratory combinations
Medically reviewed by Drugs.com. Last updated on Nov 22, 2021.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
On This Page
Rx Only
The EndaCof-DH brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
EndaCof DH Description
Each 5 mL (one teaspoonful) for oral administration contains:
| |
| Dihydrocodeine Bitartrate* | 3 mg |
| Brompheniramine Maleate | 4 mg |
| Phenylephrine Hydrochloride | 7.5 mg |
ENDACOF-DHOral Liquid also contains: Sodium benzoate, Citric acid, Saccharin sodium, Propylene glycol, Sorbitol, Flavor and Purified water.
Dihydrocodeine Bitartrate is an antitussive with the chemical name (Morphinan-6-ol 4, 5α-Epoxy-3-methoxy-17-methylmorphinan-5α, 6α )=2,3=dihydroxybutanedioate (1:1) (salt) an odorless, fine white powder is an opioid analgesic. It has the following structural formula:
